| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | 0.0062 | 0.9 |
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | -0.0063 | 0.9 |
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | 0.0065 | 0.9 |
| mRNA | AZD-2281 | FIMM | pan-cancer | AAC | 0.031 | 0.9 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | -0.0075 | 0.9 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | -0.0061 | 0.9 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.0064 | 0.9 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0063 | 0.9 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.0064 | 0.9 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | -0.0061 | 0.9 |